Product Description: Modakafusp alfa (TAK-573) is a humanized, anti-CD38 IgG4 monoclonal antibody fused to 2 attenuated IFNα2b molecules. Modakafusp alfa can be used in the research of multiple myeloma[1].
Applications: Cancer-programmed cell death
Formula: N/A
References: [1]Dan T. Vogl MD, et al. TAK-573, an Anti-CD38/Attenuated Ifnα Fusion Protein, Has Clinical Activity and Modulates the Ifnα Receptor (IFNAR) Pathway in Patients with Relapsed/Refractory Multiple Myeloma.Blood. 2020, 136 (1), 37-38.
CAS Number: 2254522-19-3
Molecular Weight: N/A
Compound Purity: 96.22
Research Area: Cancer
Solubility: 10 mM in DMSO
Target: CD38